"Located in Albuquerque’s northeast heights, Presbyterian Kaseman Hospital serves the greater Albuquerque and the east mountain communities. This satellite medical campus provides a wide range of medical care, including behavioral health, a wide range of surgical services, adult medical specialties, cancer care, rehabilitation, and an emergency department. Laboratory and radiology services are also available on-site."

During the past decade, Presbyterian Kaseman Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 27 clinical trials were completed, i.e. on average, 57.4% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 17 clinical trials were completed. i.e. 89.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presbyterian Kaseman Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presbyterian Kaseman Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Presbyterian Kaseman Hospital" are "Invasive Breast Carcinoma" (6 trials), "Stage IIIA Breast Cancer" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Presbyterian Kaseman Hospital" in a lesser frequency.

Most popular intervention types in "Presbyterian Kaseman Hospital" are "Drug" (58 trials), "Other" (49 trials), "Biological" (29 trials), "Procedure" (17 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (24 trials), "Laboratory Biomarker Analysis" (21 trials), "Questionnaire Administration" (12 trials), "Computed Tomography" (11 trials) and "Biospecimen Collection" (10 trials). Other intervention names were less common.

The vast majority of trials in "Presbyterian Kaseman Hospital" are 60 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Presbyterian Kaseman Hospital". undefined are not yet recruiting, 19 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Presbyterian Kaseman Hospital, 3 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Presbyterian Kaseman Hospital, 0 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".